Mettler-Toledo International, Inc.
MTD • NYSE
Mettler-Toledo International, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Patrick K. Kaltenbach, with a market cap of $24.9B.
CEOPatrick K. Kaltenbach
Next Earnings
Upcoming earnings announcement for Mettler-Toledo International, Inc.
Date
Thursday, April 30, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$8.70
Revenue Estimate
$939.6M
Earnings History
Past 12 earnings reports for Mettler-Toledo International, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $13.36Est: $12.78 | +4.5% | $1.1BEst: $1.1B | +2.5% |  10-K |
| Nov 6, 2025 | Q3 2025 | $11.15Est: $10.65 | +4.7% | $1.0BEst: $995.1M | +3.5% | 10-Q |
| Jul 31, 2025 | Q2 2025 | $10.09Est: $9.59 | +5.2% | $983.2MEst: $958.0M | +2.6% | 10-Q |
| May 1, 2025 | Q1 2025 | $8.19Est: $7.89 | +3.8% | $883.7MEst: $876.6M | +0.8% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $12.41Est: $11.72 | +5.9% | $1.0BEst: $1.0B | +3.5% | 10-K |
| Nov 7, 2024 | Q3 2024 | $10.21Est: $10.01 | +2.0% | $954.5MEst: $944.7M | +1.0% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $9.65Est: $9.04 | +6.7% | $946.8MEst: $929.1M | +1.9% | 10-Q |
| May 9, 2024 | Q1 2024 | $8.89Est: $7.62 | +16.7% | $925.9MEst: $879.1M | +5.3% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $9.40Est: $10.10 | -6.9% | $935.0MEst: $958.4M | -2.4% | 10-K |
| Nov 9, 2023 | Q3 2023 | $9.80Est: $9.74 | +0.6% | $942.5MEst: $949.9M | -0.8% | — |
| Jul 27, 2023 | Q2 2023 | $10.19Est: $9.97 | +2.2% | $982.1MEst: $1.0B | -1.8% | 10-Q |
| May 4, 2023 | Q1 2023 | $8.69Est: $8.60 | +1.0% | $928.7MEst: $918.7M | +1.1% | — |